Abstract
Temozolomide is an oral alkylating agent shown to have modest efficacy in the treatment of glioblastoma multiforme. Tumor necrosis factor alpha (TNF-alpha) is a polypeptide cytokine with synergistic antitumor activity in combination therapy with alkylating agents. We investigated the combined use of Ad.Egr-TNF, a replication-defective adenoviral vector encoding the cDNA for TNF-alpha under the control of chemo-inducible elements of the egr1 gene promoter, and intraperitoneal temozolomide in an intracranial human malignant glioma model. In hind limb U87MG xenografts, temozolomide produced a 6.4-fold greater induction of TNF-alpha after infection with Ad.Egr-TNF compared with Ad.Egr-TNF alone at 96 hours (P < 0.02). TNF-alpha and temozolomide combination leads to a synergistic decrease in U87 cell viability at 72 hours compared with either treatment alone (P < 0.001). Median survival for animals treated with Ad.Egr-TNF alone, temozolomide alone, and Ad.Egr-TNF/temozolomide was 21, 28, and 74 days, respectively (P < 0.001 by log-rank). Flow cytometric assessment of apoptosis revealed a synergistic increase in U87 cell apoptosis in vitro at 72 hours (P < 0.05), and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end...Continue Reading
References
Apr 1, 1991·Neurosurgery·C StraussM Berg
Nov 8, 1985·Science·L J Old
Sep 7, 1988·Journal of the National Cancer Institute·D R SpriggsD W Kufe
Apr 1, 1996·The British Journal of Surgery·E R ManusamaA M Eggermont
Feb 5, 1998·Cytometry·M van EngelandC P Reutelingsperger
Jun 6, 1998·Gene Therapy·M J StabaR R Weichselbaum
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L A HammondE K Rowinsky
Feb 5, 2000·Journal of Neurosurgery·S LalF F Lang
Jul 14, 2001·Journal of Neuro-oncology·L DuanK Hirakawa
Jan 10, 2002·Journal of Neurosurgery·M LacroixR Sawaya
Apr 9, 2002·Lancet·L A Stewart
Aug 17, 2002·Neurosurgery·Shaan M RazaRaymond Sawaya
Jul 10, 2003·The Lancet Oncology·Alexander M M EggermontTimo L M ten Hagen
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lian DuanKiyotaka Yamamoto
Jan 28, 2004·Cancer·Susan M ChangMichael D Prados
Citations
Jul 24, 2010·Neurosurgical Review·Eduard B DincaAlexandru V Ciurea
Sep 2, 2008·Cancer Gene Therapy·J J ParryB E Rogers
May 16, 2009·Cancer Gene Therapy·R R Weichselbaum, D Kufe
Aug 6, 2005·Cancer Gene Therapy·J J MezhirR R Weichselbaum
Oct 14, 2005·Anti-cancer Drugs·James J MezhirRalph R Weichselbaum
Jul 3, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marianela CandolfiMaria G Castro
May 20, 2006·Neurosurgical Focus·Vinay GuptaThomas C Chen
Sep 23, 2014·Human Gene Therapy. Clinical Development·Michael E EggerJorge G Gomez-Gutierrez
Oct 20, 2005·Cancer Science·Wei-dong WangZheng-huai Cao
Jan 16, 2015·Cell Cycle·Clayton D CrawleyBakhtiar Yamini
Oct 4, 2005·Neurological Research·Christian W Sikorski, Maciej S Lesniak
May 23, 2015·Therapeutic Delivery·Drew A SpencerMaciej S Lesniak
Mar 31, 2015·BioMed Research International·Salvatore ParisiGuido Valle
Jun 13, 2006·Neuroscience·S KarmakarS K Ray
Sep 25, 2014·Molecular Carcinogenesis·Chandagirikoppal V KavithaGagan Deep
Feb 12, 2008·The Journal of Gene Medicine·Stanimira RohmerDirk M Nettelbeck
Apr 21, 2006·Expert Review of Neurotherapeutics·Maciej S Lesniak
Aug 19, 2007·Neurochemical Research·Surajit KarmakarSwapan K Ray
May 6, 2009·Journal of Neuro-oncology·Tara A BaroneRobert J Plunkett
Oct 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bakhtiar YaminiRalph R Weichselbaum
Jul 20, 2007·Cancer Research·Bakhtiar YaminiRalph R Weichselbaum
Apr 4, 2019·Cancer Research·David J VoceBakhtiar Yamini
Mar 27, 2015·Cancer Research·Nassir M MansourBakhtiar Yamini
Mar 13, 2021·Scientific Reports·David J VoceBakhtiar Yamini
Apr 8, 2021·Radiation Research·David CernaMansoor M Ahmed
Nov 21, 2007·Surgical Oncology Clinics of North America·Medina C KushenMaciej S Lesniak